Onyx Pharmaceuticals, 249 E Grand Ave, South San Francisco, CA 94080, US

Exelixis is a South San Francisco-based biopharmaceutical company dedicated to advancing the treatment of cancer. With a comprehensive approach that encompasses diverse biotherapeutics and small molecule programs, Exelixis is at the forefront of innovation in cancer care. Through strategic partnerships and in-house research and development, the company is developing next-generation cancer medicines, exploring multiple modalities and mechanisms of action to challenge the status quo and bring hope to patients. Driven by a shared purpose and a team of over 1,200 employees, Exelixis is committed to making a meaningful impact in oncology. Their mission is to create treatment regimens that not only extend survival but also improve the quality of life for cancer patients. With a focus on fostering a diverse and collaborative workforce, Exelixis is dedicated to creating an exceptional employee experience that fuels their innovative drug discovery, development, and commercialization efforts.Generated from the website